Bio-Techne expands global GMP manufacturing network with new Bristol facility to advance scalable cell therapy development

The Medical News ·
Health & Medicine United Kingdom

Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the opening of a new manufacturing facility for Good Manufacturing Practice (GMP) grade small molecules in Bristol, United Kingdom, further expanding the company's global capabilities to support the rapidly growing cell therapy market.

Read original article on The Medical News →

Related news